REMEDi4ALL researchers based at the Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP) and Fraunhofer…
tools@teamitresearch.com24 May 2024
On 7 March 2024, over 80 attendees representing (non-) governmental funders, philanthropic entities, and pharmaceutical…
tools@teamitresearch.com18 April 2024
Over 250 experts from around the globe gathered in Barcelona for the inaugural International Drug…
tools@teamitresearch.com17 April 2024
The #iDR24 conference hosted a dynamic Poster Session, providing a vibrant platform to showcase cutting-edge…
tools@teamitresearch.com17 April 2024
Looking for funding for drug repurposing projects can be difficult - many funders do not…
tools@teamitresearch.com12 April 2024
The UCL Translational Research Office led a UCL academic delegation to join the first international…
admin27 March 2024
Exciting insights from #iDR24! Oriol Güell from El País explores the enormous potential of drug…
admin11 March 2024
At the 20th Annual WORLD Symposium in San Diego this February, the global spotlight shone…
Piret Baur21 February 2024
In March 2023, a Curriculum Setting Meeting took place to define what the REMEDi4ALL consortium…
tools@teamitresearch.com18 January 2024
Pancreatic cancer, a rare and hard to treat type of cancer, is one of four…
tools@teamitresearch.com12 December 2023
Tazarotene, originally approved as a topical cream for psoriasis and acne, will be investigated as…
admin13 October 2023
, Horizon Magazine published an article on drug repurposing featuring REMEDi4ALL project. According to the…
Ivette Corominas30 November 2022
Virginie Hivert, Director of Therapeutic Development at Eurordis, was recently interviewed by Phamaceutiques
Ivette Corominas30 November 2022
Every year, approximately 140.000 people are diagnosed with pancreatic cancer in Europe. This is one…
Ivette Corominas17 November 2022
The iconic building The Eye in central Amsterdam, welcomed the REMEDi4ALL Consortium last September for…
Gisela Pairo4 November 2022
Researchers from Oswaldo Cruz Foundation - Fiocruz - in Brazil, have published a paper on…
Piret Baur28 October 2022
REMEDi4ALL has just launched a call inviting research funders to share their experience and ideas…
Gisela Pairo28 October 2022
REMEDi4ALL, an ambitious EU-funded research initiative, launches today to drive forward the repurposing of medicines…
admin1 September 2022
The repurposing of existing medicines has the potential to greatly improve public health outcomes, especially on neglected and rare…
admin24 August 2022
Sign up to receive the latest project-related news and opportunities
You can unsubscribe at any time.
